Results 161 to 170 of about 6,690,892 (354)
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric +10 more
wiley +1 more source
Comfort-Oriented Pothole Traversal Using Multi-Sensor Perception and Fuzzy Control. [PDF]
Yuan C +7 more
europepmc +1 more source
Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni +11 more
wiley +1 more source
Dragonfly-Wing-Inspired Bluff-Body Piezoelectric Harvester for Efficient Low-Wind-Speed Energy Harvesting. [PDF]
Zhou Z, Shang X, Xia Y, Zhu P.
europepmc +1 more source
One Observer Universe: A Geometric Interpretation of Speed of Light and Mass
Ahmed Farag Ali
openalex +2 more sources
Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova +14 more
wiley +1 more source
Laser Wire Directed Energy Deposition of 5356 Aluminum Alloy: Process Parameter Optimization and Porosity Prediction. [PDF]
Zhang X, Mei Y, Yang H, Zhou S.
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source

